As of 2024-12-11, the Intrinsic Value of Abbott Laboratories (ABT) is
132.48 USD. This Abbott valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 115.50 USD, the upside of Abbott Laboratories is
14.70%.
The range of the Intrinsic Value is 88.01 - 275.11 USD
132.48 USD
Intrinsic Value
Abbott Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
88.01 - 275.11 |
132.48 |
14.7% |
| DCF (Growth 10y) |
104.27 - 302.41 |
151.68 |
31.3% |
| DCF (EBITDA 5y) |
108.31 - 138.71 |
117.92 |
2.1% |
| DCF (EBITDA 10y) |
119.46 - 160.16 |
133.82 |
15.9% |
| Fair Value |
76.82 - 76.82 |
76.82 |
-33.49% |
| P/E |
117.88 - 154.03 |
131.59 |
13.9% |
| EV/EBITDA |
107.55 - 141.76 |
116.65 |
1.0% |
| EPV |
64.25 - 86.42 |
75.33 |
-34.8% |
| DDM - Stable |
37.51 - 146.77 |
92.14 |
-20.2% |
| DDM - Multi |
76.67 - 219.86 |
112.15 |
-2.9% |
Abbott Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
200,330.12 |
| Beta |
0.11 |
| Outstanding shares (mil) |
1,734.46 |
| Enterprise Value (mil) |
207,751.12 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.62% |
| Cost of Debt |
4.28% |
| WACC |
7.35% |